Analyst Ratings For Aduro Biotech (NASDAQ:ADRO)
Today, Cowen and Company initiated coverage on Aduro Biotech (NASDAQ:ADRO) with a Outperform.
There are 7 buy ratings on the stock.
The current consensus rating on Aduro Biotech (NASDAQ:ADRO) is Buy (Score: 3.00) with a consensus target price of $20.00 per share, a potential 52.38% upside.
Some recent analyst ratings include
- 7/18/2017-Cowen and Company initiated coverage with a Outperform rating.
- 5/3/2017-Canaccord Genuity Reiterated Rating of Buy.
- 5/1/2017-HC Wainwright initiated coverage with a Buy rating.
- 5/1/2017-Rodman & Renshaw initiated coverage with a Buy rating.
- 3/7/2017-FBR & Co Reiterated Rating of Buy.
- 3/7/2017-Roth Capital Reiterated Rating of Buy.
Recent Insider Trading Activity For Aduro Biotech (NASDAQ:ADRO)
Aduro Biotech (NASDAQ:ADRO) has insider ownership of 6.60% and institutional ownership of 35.65%.
- On 7/6/2017 Thomas W Dubensky, Insider, sold 50,000 with an average share price of $11.33 per share and the total transaction amounting to $566,500.00. View SEC Filing
- On 7/5/2017 Stephen T Isaacs, Insider, sold 40,000 with an average share price of $11.06 per share and the total transaction amounting to $442,400.00. View SEC Filing
- On 7/3/2017 Dirk G Brockstedt, EVP, sold 10,000 with an average share price of $11.02 per share and the total transaction amounting to $110,200.00. View SEC Filing
- On 7/3/2017 Jennifer Lew, Insider, sold 12,000 with an average share price of $11.14 per share and the total transaction amounting to $133,680.00. View SEC Filing
- On 6/28/2017 Gregory W Schafer, COO, sold 40,000 with an average share price of $11.26 per share and the total transaction amounting to $450,400.00. View SEC Filing
- On 6/28/2017 Jennifer Lew, Insider, sold 12,000 with an average share price of $11.19 per share and the total transaction amounting to $134,280.00. View SEC Filing
- On 6/19/2017 Stephen T Isaacs, Insider, sold 40,000 with an average share price of $10.50 per share and the total transaction amounting to $420,000.00. View SEC Filing
Recent Trading Activity for Aduro Biotech (NASDAQ:ADRO)
Shares of Aduro Biotech closed the previous trading session at 13.04 down -0.06 -0.46% with 306,192 shares trading hands.